Ribbon Communications Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ribbon Communications Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $226.40M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $203.16M | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | $210.62M | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | $186.16M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $233.64M | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | $207.13M | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | $205.80M | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | $173.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $230.58M | Mar 31, 2023 |
| FY2022 | Sep 30, 2021 | $210.40M | Mar 31, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $844.56M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $833.88M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $826.34M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $819.76M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $844.96M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $843.80M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $563.11M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $577.91M | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $420.71M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $439.51M | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $121.71M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $103.50M | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | $101.47M | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | $81.40M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $114.01M | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | $104.32M | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | $104.55M | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | $78.06M | Feb 28, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.64M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($54.24M) | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $7.08M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | ($13.50M) | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | ($21.48M) | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | ($38.31M) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $20.49M | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | ($18.42M) | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | ($30.18M) | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | ($69.98M) | Feb 28, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.32M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $16.87M | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $16.67M | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | $856.0K | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | ($6.62M) | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | ($35.19M) | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $1.27M | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | ($3.30M) | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | ($7.24M) | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | ($39.05M) | Feb 28, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $178.87M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $179.94M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $190.66M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $203.68M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $194.95M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $194.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $141.06M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $145.46M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $101.48M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $72.84M | Mar 5, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $50.24M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $17.09M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($26.36M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $19.18M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $101.56M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $55.69M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | ($9.60M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $8.08M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $19.19M | Mar 5, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.34M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $22.41M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $9.38M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $10.25M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $17.13M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $26.72M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $10.82M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $7.91M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $4.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $4.63M | Mar 5, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.16B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.14B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.26B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.35B | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.55B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $814.91M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $957.16M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $910.88M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $308.06M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $763.26M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $757.93M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $691.39M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $737.14M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $820.57M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $860.41M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $331.65M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $366.86M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $295.46M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $88.94M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $448.99M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $404.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $452.76M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $518.43M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $527.17M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $686.85M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $483.26M | Mar 31, 2023 |
| FY2021 | Dec 31, 2018 | $590.30M | Mar 11, 2022 |
| FY2020 | Dec 31, 2017 | $615.42M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $219.12M | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $300.89M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $300.89M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $300.89M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $300.89M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $300.89M | Mar 31, 2023 |
| FY2022 | Dec 31, 2020 | $416.89M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $224.90M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $383.66M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $335.72M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $49.39M | Mar 5, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.53B) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($1.57B) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($1.52B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($1.45B) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($1.36B) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($1.18B) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($1.27B) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($1.14B) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($1.07B) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($1.04B) | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.41M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $87.77M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $26.49M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $67.26M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $103.92M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $128.43M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $44.64M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $43.69M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $57.07M | Mar 5, 2019 |
| FY2018 | Dec 31, 2016 | $31.92M | Mar 5, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $342.13M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $348.25M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $235.40M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $330.45M | Feb 28, 2024 |
| FY2019 | Dec 31, 2018 | $55.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $20.00M | Mar 5, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 28, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 28, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 28, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 175.78M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 175.60M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 172.08M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 168.32M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 148.90M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 145.43M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 110.47M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 106.82M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 101.75M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | 49.04M | Mar 8, 2018 |